Release of copper and indomethacin from intrauterine devices immersed in simulated uterine fluid

Eur J Contracept Reprod Health Care. 2010 Jun;15(3):205-12. doi: 10.3109/13625181003782860.

Abstract

Objectives: To study the release of cupric ions and indomethacin from copper-bearing intrauterine devices (Cu-IUDs) and to assess the influence of their surface area of copper and the pH of the test medium on the release of cupric ions.

Methods: Cu-IUDs were incubated in simulated uterine fluid (SUF). The in vitro release of cupric ions and indomethacin was determined by means of a flame atomic absorption spectrometer and a UV 752 spectrophotometer, respectively, over a period of 220 days. The effect of indomethacin on the pH of the SUF was monitored during the cupric ions release study.

Results: The Cu-IUDs released cupric ions in vitro according to a biphasic pattern. After an initial burst release, the rate slowed down and then became steady. The release of indomethacin from two medicated Cu-IUDs was biphasic and, in both cases, in accordance with the in vitro dissolution model of the drug. The surface area of copper of Cu-IUDs and the pH change induced by indomethacin incorporated in their frame affected the release rate of copper (p < 0.05).

Conclusion: The surface area of the copper and the pH of the test medium modulate the in vitro release of cupric ions from Cu-IUDs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Fluids / metabolism*
  • Copper / pharmacokinetics*
  • Female
  • Humans
  • In Vitro Techniques
  • Indomethacin / pharmacokinetics*
  • Intrauterine Devices, Copper*
  • Spectrophotometry, Atomic / methods
  • Uterus / metabolism*

Substances

  • Copper
  • Indomethacin